$MRK Phase 2 Study of Azacitidine in Combination With Pembrolizumab in Relapsed/Refractory Acute Myeloid Leukemia (AML) Patients and in Newly Diagnosed Older (‰¥65 Years) AML Patients…NCT02845297. Estimated Primary Completion Date -  07/2020